Dementias Terminated Phase 4 Trials for Amantadine (DB00915)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00127114Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)Treatment